Scintimammography

RADIATION3 trials

Sponsors

M.D. Anderson Cancer Center, Mayo Clinic

Conditions

Breast CarcinomaBreast NeoplasmEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor NegativeTriple-Negative Breast Carcinoma

Early Phase 1

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Active, not recruitingNCT02744053

M.D. Anderson Cancer CenterEstrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative +1

Start: 2016-11-07End: 2026-04-30Updated: 2025-10-20

Unknown Phase

Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue

CompletedNCT03220893

Mayo ClinicBreast Carcinoma

Start: 2017-06-14End: 2024-11-01Updated: 2026-02-20

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

RecruitingNCT06058650

Mayo ClinicBreast Neoplasm

Start: 2021-08-26End: 2026-08-26Target: 70Updated: 2025-09-30

Related Papers

Molecular Breast Imaging Biopsy with a Dual-Detector System

Radiology Imaging Cancer2024-06-015 citations

Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer–weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study

Radiology Imaging Cancer2021-09-0126 citations